http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200018508-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2018-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_798108b9c34bf512eb51ccda3d646793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78e95eb50a055e13b580f27b5c0aa516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d99eed36c8c2e1f9b6a91fe4c93912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8005bb37e5334e938ecd1e99f137658d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe12280048602e0e212278d5fc4dc108 |
| publicationDate | 2020-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200018508-A |
| titleOfInvention | MiRNA-574-5p as Biomarker for Stratification of Prostaglandin E-dependent Tumors |
| abstract | The present invention relates to the field of diagnostic methods. More particularly, the present invention relates to determining the amount of microRNA-574-5p in a subject's test sample, comparing the determined amount to a reference, and subjecting a prostaglandin E-dependent tumor to prostaglandin E formation based on the comparison. A method for confirming that a subject suffering from a prostaglandin E-dependent tumor is susceptible to a therapy using an inhibitor of prostaglandin E formation, the method comprising identifying that the therapy is susceptible to a therapy using an inhibitor. In addition, the present invention also provides a detection agent that specifically binds to microRNA-574-5p or a sample in a subject with a prostaglandin E-dependent tumor to confirm that the subject is sensitive to therapy with inhibitors of prostaglandin E formation. And kits including equipment for carrying out the methods of the present invention. |
| priorityDate | 2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 336.